Skip to main content
SpringerLink
Log in

Reduction of the somatotrope responsiveness to GHRH and Hexarelin but not to arginine plus GHRH in hyperprolactinemic patients

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Aim of the present study was to verify the maximal secretory capacity of somatotrope cells in patients with pathological hyperprolactinemia (HPRL) comparing it with that in normal age-matched women (NW). To this goal in 12 HPRL normal weight patients (age 28.6±2.6 yr, BMI 23.1 ±1.1 kg/m2) and 8 NW (27.2±0.8 yr, 22.8±0.8 kg/m2) we studied the GH response to GHRH (1µg/kg iv), GHRH plus arginine (ARG, 0.5 g/kg iv), an amino acid probably acting at the hypothalamic level inhibiting somatostatin release, and Hexarelin (HEX, 2 µg/kg iv), a synthetic hexapeptide belonging to GHRP family, which acts concomitantly at the pituitary and the hypothalamic level. IGF-I levels in HPRL were similar to those in NW (179.2±16.5 µg/l and 218.5±30.8 µg/l). In NW the GH response to GHRH (AUC: 1299.5±186.9 µg.90 min/l) was lower (p<0.02) than those to GHRH+ARG (5252.7±846.3 µg.90 min/l) and HEX (3216.6±462.3 µg.90 min/l) which, in turn, were similar. In HPRL the GH response to GHRH (894.7±242.4 µg.90 min/l) was lower (p<0.03) than that to HEX (1586.5±251.3 µg.90 min/l) and both were lower (p<0.03) than that to GHRH+ARG (4468.8±941.7 µg.90 min/l). In HPRL the GH responses to GHRH and HEX were lower than those that in NW (p<0.03) while that to GHRH+ARG was similar in both groups. These results demonstrate that the somatotrope responsiveness to GHRH and HEX is clearly reduced in patients with pathological hyperprolactinemia. On the other hand, in this condition the GH response to GHRH+ARG is normal. As arginine likely acts via inhibition of hypothalamic somatostatin release, these findings show that the maximal secretory capacity of somatotrope cells in hyperprolactinemia is preserved and indicate that partial refractoriness of somatotrope cells to GHRH and HEX could be due to somatostatinergic hyperactivity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Clemmons D.R., Underwood L.E., Ridgway E.C., Kliman B., Van Wyk J.J. Hyperprolactinemia is associated with increased im-munoreactive somatomedin C in hypopituitarism. J. Clin. Endocrinol. Metab. 52: 731, 1981.

    Article  PubMed  CAS  Google Scholar 

  2. Kelly P.A., Djiane J., Postel-Vinay M.C., Edery M.C. The prolactin growth hormone receptor family. Endocr. Rev. 12: 235, 1991.

    Article  PubMed  CAS  Google Scholar 

  3. Ciccarelli E., Grottoli S., Razzore P., Gianotti L., Arvat E., Deghenghi, R., Camanni F., Ghigo E. Hexarelin, a synthetic growth hormone releasing peptide, stimulates prolactin secretion in acromegalic but not in hyperprolactinaemic patients. Clin. Endocrinol. (Oxf.) 44: 67, 1996.

    Article  CAS  Google Scholar 

  4. Chang R.J., Keye W.R., Monroe S.E., Jaffe R.B. Prolactin-secreting pituitary adenomas in women. IV. Pituitary function in amenorrhoea associated with normal or abnormal serum prolactin and sellar poly-tomography. J. Clin. Endocrinol. Metab. 46: 459, 1980.

    Google Scholar 

  5. Ghigo E., Arvat E., Muccioli G., Camanni F. Growth hormone (GH)-releasing peptides. Eur. J. Endocrinol 136: 445, 1997.

    Article  PubMed  CAS  Google Scholar 

  6. Scanion M.F., Rodriguez-Arnao M.D., McGregor A.M., Weightmann D.R., Lewis M., Cook D.B., Gomez-Pan A., Hall R. Altered dopaminergic regulation of thyrotropin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function. Clin. Endocrinol. (Oxf.) 14: 133, 1981.

    Article  Google Scholar 

  7. Camanni F., Ciccarelli E., Ghigo E., Müller E.E. Hyperprolactinemia: neuroendocrine and diagnostic aspects. J. Endocrinol. Invest. 12: 653, 1989.

    Article  PubMed  CAS  Google Scholar 

  8. Müller E.E., Nisticò G. Neuroregulation of the anterior pituitary. In: Müller E.E., Nisticò G. (Eds), Brain messangers and the pituitary. Academic Press, San Diego, 1989, p. 404.

    Google Scholar 

  9. Landgraf R., Landgraf-Leurs M.M.C., Weissmann A., Hörl R., von Werder K., Scriba P.C. Prolactin: a diabetogenic hormone. Diabetologia 13: 99, 1977.

    Article  PubMed  CAS  Google Scholar 

  10. Schernthaner G., Prager R., Punzengruber C., Luger A. Severe hyperprolactinemia is associated with decreased insulin binding in vitro and insulin resistance in vivo. Diabetologia 28: 138, 1985.

    PubMed  CAS  Google Scholar 

  11. Maccario M., Grottoli S., Razzore P., Procopio M., Oleandri S.E., Ciccarelli E., Camanni F., Ghigo E. Effects of glucose load and/or arginine on insulin and growth hormone secretion in hyperprolactinemia and obesity. Eur. J. Endocrinol. 135: 205, 1996.

    Article  PubMed  CAS  Google Scholar 

  12. Ghigo E. Neurotransmitter control of growth hormone secretion. Regulation of growth hormone and somatic growth. In: De la Cruz L.F. (Eds), Growth hormone and somatic growth. Excerpta Medica, Amsterdam, 1992, p. 103.

    Google Scholar 

  13. Alba-Roth J., Albrecht Muller A.O., Schopohl J., Von Werder K. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J. Clin. Endocrinol. Metab. 67: 1186, 1988.

    Article  PubMed  CAS  Google Scholar 

  14. Dallabonzana D., Spelta B., Botalla L., Oppizzi G., Silvestrini F., Chiodini P.G., Liuzzi A. Effects of nomifensine on growth hormone and prolactin secretion in normal subjects and in pathological hyperprolactinemia. J. Clin. Endocrinol. Metab. 54: 1125, 1982.

    Article  PubMed  CAS  Google Scholar 

  15. Faglia G., Beck-Peccoz P., Travaglini P., Ambrosi B., Rondena M., Paracchi A., Spada A., Weber G., Bara R., Rouzin A. Functional studies in hyperprolactinemic states. In: Crosignani P.G., Robyn C. (Eds.), Prolactin and human reproduction. Academic Press, London, 1977, p. 225.

    Google Scholar 

  16. Müller E.E., Cavagnini F., Martinez-Campos A., Maraschini C., Giovannini P., Novelli A., De Leo V. Dynamics testing of prolactin and growth hormone secretion in patients with neuroendocrine disorders. Acta Endocrinol. (Copenh.) 107: 155, 1984.

    Google Scholar 

  17. Corpas E., Harman SM., Blackman G. Human growth hormone and human aging. Endocr. Rev. 14: 20, 1993.

    Article  PubMed  CAS  Google Scholar 

  18. Ghigo E., Goffi S., Nicolosi M., Arvat E., Procopio M., Bellone J., Mazza E., Camanni F. Growth hormone (GH) responsiveness to combined administration of arginine and GHRH-releasing hormone does not vary with age in man. J. Clin. Endocrinol. Metab. 71: 1481, 1990.

    Article  PubMed  CAS  Google Scholar 

  19. Ghigo E., Goffi S., Arvat E., Imperiale E., Boffano G.M., Valetto M.R., Mazza E., Santi I., Magliona A., Boghen M.F., Boccuzzi G., Camanni F. A neuroendocrinological approach to evidence an impairment of central cholinergic function in aging. J. Endocrinol. Invest. 15: 665, 1992.

    Article  PubMed  CAS  Google Scholar 

  20. Ghigo E., Aimaretti G., Gianotti L., Bellone J., Arvat E., Camanni F. New approach to the diagnosis of growth hormone deficiency in adults. Eur. J. Endocrinol. 134: 352, 1996.

    Article  PubMed  CAS  Google Scholar 

  21. Fukata J., Diamond D.J., Martin J.B. Effects of rats growth hormone (rGH)-releasing factor and somatostatin on the release and synthesis of rGH in dispersed pituitary cells. Endocrinology 117: 457, 1985.

    Article  PubMed  CAS  Google Scholar 

  22. Ross R.J.M., Borges F., Grossman A., Smith R., Ngahfoong L., Rees L.H., Savage M.O., Besser G.M. Growth hormone pretreatment in man blocks the response to growth hormone-releasing hormone; evidence for a direct effect of growth hormone. Clin. Endocrinol. (Oxf.) 26: 117, 1987.

    Article  CAS  Google Scholar 

  23. Massara F., Ghigo E., Goffi S., Molinatti G.M., Müller E.E., Camanni F. Blockade of hp GRF-40-induced GH release in normal man by cholinergic muscarinic antagonist. J. Clin. Endocrinol. Metab. 59: 1025, 1984.

    Article  PubMed  CAS  Google Scholar 

  24. Ghigo E., Bellone J., Arvat E., Mazza E., Cella S.G., Brambilla F., Müller E.E., Camanni F. Effects of alpha- and beta adrenergic agonists and antagonists on growth hormone secretion in man. J. Neuroendocrinol. 2: 473, 1990.

    Article  PubMed  CAS  Google Scholar 

  25. Davies R.R., Turner S., Johnston D.G. Oral glucose inhibits growth hormone secretion induced by human pancreatic growth factor 1–44 in normal man. Clin. Endocrinol. (Oxf.) 21: 477, 1984.

    Article  CAS  Google Scholar 

  26. Arvat E., Gianotti L., Di Vito L., Imbimbo B.P., Lenaerts V., Deghenghi R., Camanni F., Ghigo E. Modulation of growth hormone-releasing activity of hexarelin in man. Neuroendocrinology 61: 51, 1995.

    Article  PubMed  CAS  Google Scholar 

  27. Maccario M., Arvat E., Procopio M., Gianotti L., Grottoli S., Imbimbo B.P., Lenaerts V., Deghenghi R., Camanni F., Ghigo E. Metabolic modulation of the growth hormone-releasing activity of hexarelin in man. Metabolism 44: 134, 1995.

    Article  PubMed  CAS  Google Scholar 

  28. Ghigo E., Arvat E., Gianotti L., Ramunni J., Maccario M., Camanni F. Interaction of salbutamol with pyridostigmine and arginine on both basal and GHRH-stimulated GH secretion in humans. Clin. Endocrinol. (Oxf.) 40: 799, 1994.

    Article  CAS  Google Scholar 

  29. Ghigo E., Miola C., Aimaretti G., Valente F., Procopio M., Arvat E., Yin-Zhang W., Camanni F. Arginine abolishes the inhibitory effect of glucose on the GH response to GHRH in man. Metabolism 41: 209, 1992.

    Google Scholar 

  30. Walsh R.J., Slabby F.J., Posner B.L. A receptor mediated mechanism for the transport of prolactin from blood to cerebrospinal fluid. Endocrinology 120: 1846, 1987.

    Article  PubMed  CAS  Google Scholar 

  31. Melmed S. Insulin suppresses growth hormone secretion by rat pituitary cells. J. Clin. Invest. 73: 1425, 1984.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  32. Jones J.I., Clemmons D.R. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16: 3, 1995.

    PubMed  CAS  Google Scholar 

  33. Tannenbaum G.S., Guyda H.J., Posner B.I. Insulin-like growth factors: a role in growth hormone negative feedback and body weight regulation via brain. Science 220: 77, 1983.

    Article  PubMed  CAS  Google Scholar 

  34. Berelowitz M., Szabo M., Frohoman L.A., Firestone S., Chu L., Hintz R.L. Somatomedin-C mediates growth hormone negative feedback by effects on both hypothalamus and the pituitary. Science 113: 12, 1981.

    Google Scholar 

  35. Houston B., O’Neill I.E. Insulin and growth hormone act synergistically to stimulate insulin-like growth factor production by cultured chicken hepatocytes. J. Endocrinol. 128: 389, 1991.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisione di Endocrinologia, Dipartimento di Medicina Interna, Università di Torino, Torino, Italy

    S. Grottoli, P. Razzore, E. Arvat, S. E. Oleandri, R. Rossetto, E. Ciccarelli, F. Camanni & E. Ghigo MD

Authors
  1. S. Grottoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Razzore
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Arvat
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. E. Oleandri
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Rossetto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E. Ciccarelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. F. Camanni
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. E. Ghigo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Grottoli, S., Razzore, P., Arvat, E. et al. Reduction of the somatotrope responsiveness to GHRH and Hexarelin but not to arginine plus GHRH in hyperprolactinemic patients. J Endocrinol Invest 20, 597–602 (1997). https://doi.org/10.1007/BF03346916

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03346916

Key-words

Search

Navigation